More...
More...
More...
More...
Cancer Research UK’s spin-out, GammaDelta Therapeutics, has been given approval to trial its unique T-cell therapy in the US.
We cover the latest cancer research, including that funded by the charity. We also highlight other relevant material, debunk myths and media scares, and provide links to other helpful resources.
Text from Cancer Research UK's News site by Cancer Research UK, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License.